Compare · BSX vs ISRG
BSX vs ISRG
Side-by-side comparison of Boston Scientific Corporation (BSX) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. BSX focuses on Medical/Dental Instruments, while ISRG focuses on Industrial Specialties.
- ISRG is the larger of the two at $155.83B, about 2.4x BSX ($65.41B).
- Over the past year, BSX is down 56.6% and ISRG is down 21.5% - ISRG leads by 35.1 points.
- ISRG has been more active in the news (15 items in the past 4 weeks vs 12 for BSX).
- Both have 25 recent analyst ratings on file.
- Company
- Boston Scientific Corporation
- Intuitive Surgical Inc.
- Price
- -
- -
- Market cap
- $65.41B
- $155.83B
- 1M return
- +4.25%
- +6.52%
- 1Y return
- -56.63%
- -21.51%
- Industry
- Medical/Dental Instruments
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2000
- News (4w)
- 12
- 15
- Recent ratings
- 25
- 25
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest BSX
- Chairman, President & CEO Mahoney Michael F received a gift of 252,241 shares (SEC Form 4)
- SVP, Chief HR Officer O'Sullivan Miriam converted options into 3,871 shares and covered exercise/tax liability with 1,872 shares, increasing direct ownership by 11% to 19,565 units (SEC Form 4)
- Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock
- SEC Form 10-Q filed by Boston Scientific Corporation
- SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints
- Boston Scientific downgraded by TD Cowen with a new price target
- Penumbra, Inc. Reports Third Quarter 2026 Financial Results
- Boston Scientific downgraded by Oppenheimer
- Boston Scientific downgraded by Analyst with a new price target
- SEC Form 8-K filed by Boston Scientific Corporation
Latest ISRG
- Director Guthart Gary S sold $4,573,370 worth of shares (10,000 units at $457.34) as part of a pre-agreed trading plan (SEC Form 4)
- Director Barratt Craig H exercised 1,150 shares at a strike of $90.49 and sold $529,003 worth of shares (1,150 units at $460.00) as part of a pre-agreed trading plan (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Intuitive Appoints Aaron Martin to its Board of Directors
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $55,896 worth of shares (124 units at $450.77) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 457 units (SEC Form 4)
- VP Corporate Controller Widman Fredrik exercised 5,448 shares at a strike of $201.07 and sold $2,375,628 worth of shares (5,448 units at $436.06) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $82,044 worth of shares (183 units at $448.33) as part of a pre-agreed trading plan (SEC Form 4)
- Director Barratt Craig H sold $510,370 worth of shares (1,150 units at $443.80) as part of a pre-agreed trading plan (SEC Form 4)
- VP Corporate Controller Widman Fredrik sold $1,834,124 worth of shares (4,047 units at $453.21) as part of a pre-agreed trading plan (SEC Form 4)
- SVP Chief Human Resources Offi Wadors Patricia L sold $478,416 worth of shares (1,078 units at $443.80) as part of a pre-agreed trading plan (SEC Form 4)